FLIP sync: Collaboration for inhibitors and cancer treatments
Ipsen and Domainex collaboration will provide an exclusive licence to develop innovative inhibitors and pioneering cancer treatments - News - PharmaTimes
Source: pharmatimes.com
Mcclay Professor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mcclay Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mcclay Professor Today - Breaking & Trending Today
Queen's University Belfast enters collaboration and licensing agreement with Ipsen to progress FLIP inhibitor project which has been supported by Domainex
Saffron Walden, 26th January 2022 / Sciad Newswire / Domainex Ltd., a leading provider of integrated drug discovery services to life science organisations globally, is delighted that Professors Daniel Longley, Tim Harrison and colleagues at Queen’s University Belfast have entered into a collaboration and licensing a...
Source: pharmiweb.com